According to Intent Market Research, the Basal Cell Carcinoma Treatment Market is expected to grow from USD 6.3 billion in 2023 at a CAGR of 10.4% to touch USD 12.5 billion by 2030. The Basal Cell Carcinoma Treatment Market is dominated by key players such as, Merck & Co., Inc., Bristol-Myers Squibb... Read More
According to Intent Market Research, the Barth Syndrome Treatment Market is expected to grow from USD 0.4 billion in 2023 at a CAGR of 12.7% to touch USD 0.8 billion by 2030. The Barth Syndrome Treatment Market is dominated by key players such as, GlaxoSmithKline Plc, Pfizer Inc., AbbVie Inc., Alnyl... Read More
According to Intent Market Research, the Behcet's Syndrome Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 10.4% to touch USD 1.8 billion by 2030. The Behcet's Syndrome Market is dominated by key players such as, Roche Holding AG, Novartis AG, Amgen Inc., Pfizer Inc., and Merck ... Read More
According to Intent Market Research, the Estrogen Blockers Market is expected to grow from USD 13.9 billion in 2023 at a CAGR of 6.8% to touch USD 22.1 billion by 2030. The Estrogen Blockers Market is dominated by key players such as AstraZeneca, Novartis, Pfizer, Eli Lilly and Company, Merck & Co.,... Read More
According to Intent Market Research, the ESR Tubes Market is expected to grow from USD 0.5 billion in 2023 at a CAGR of 6.9% to touch USD 0.7 billion by 2030. The ESR Tubes Market is dominated by key players such as BD, Greiner Bio-One International GmbH, Terumo Corporation, Cardinal Health, Inc., T... Read More
According to Intent Market Research, the ESR Analyzer Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 4.3% to touch USD 7.5 billion by 2030. The ESR Analyzer Market is dominated by key players such as Alifax S.r.l., Streck, Inc., Beckman Coulter, Inc., Transasia Bio-Medicals Ltd... Read More
According to Intent Market Research, the Escherichia Coli Strain Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 6.5% to touch USD 2.6 billion by 2030. The Escherichia Coli Strain Market is dominated by key players such as Thermo Fisher Scientific, Becton, Dickinson and Company ... Read More
According to Intent Market Research, the Erythropoietin Drugs Market is expected to grow from USD 6.5 billion in 2023 at a CAGR of 1.9% to touch USD 7.4 billion by 2030. The Erythropoietin Drugs Market is dominated by key players such as Amgen Inc., Roche Holding AG, Johnson & Johnson, Novartis AG, ... Read More
According to Intent Market Research, the Erythromycin Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 6.3% to touch USD 0.9 billion by 2030. The Erythromycin Market is dominated by key players such as Pfizer Inc., Eli Lilly and Company, Teva Pharmaceuticals, Bristol-Myers Squibb... Read More
According to Intent Market Research, the Ephedrine Market is expected to grow from USD 1.8 billion in 2023 at a CAGR of 4.9% to touch USD 2.5 billion by 2030. The Ephedrine Market is dominated by key players such as Mylan N.V., Teva Pharmaceutical Industries Ltd., Amgen Inc., Eli Lilly and Co., Sand... Read More